Healthcare Tips: StemCells terminates mid-stage study; to wind down operations

(Reuters) - StemCells Inc said on Tuesday it had terminated a mid-stage trial in spinal cord injury and that its board had decided to wind down the company.

Read more: StemCells terminates mid-stage study; to wind down operations